ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 48526 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 48526; 2) Community: the network communities that were significantly associated with the response to NSC 48526; 3) Molecule: the relationships between components within communities and NSC 48526; 4) MDR: the compounds that were significantly associated with the NSC 48526.

NSC Compound Enrichment Correlation
NSC 656210 Null 0.0430505868034761 0.14842195
NSC 670284 Null 0.0430505868034761 0.25748455
NSC 672116 9-.alpha.-Acetoxyparthenolide 0.0430505868034761 0.16717235
NSC 673267 IL4(38-37)-PE38KDEL 0.0430505868034761 -0.052361589
NSC 673348 9,10-Anthracenedione, 1-[(oxiranylmethyl)amino]- 0.0430505868034761 0.21970244
NSC 67586 2-Naphthacenecarboxamide, N-[[(6,7-dihydro-7-oxo-1H-1,2,3-triazolo[4,5-d]pyrimidin-5-yl)amino]methyl]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, 0.0430505868034761 0.12299002
NSC 677696 Benzoic acid, 4-[[(2,5-dihydroxyphenyl)methyl]amino]- tert-butyl ester 0.0430505868034761 0.054551176
NSC 6777 Null 0.0430505868034761 -0.31951885
NSC 681643 Camptothecin Derivative 0.0430505868034761 0.12764905
NSC 694489 Benz[b]acridine-12-acetaldehyde, 6,11-dihydro- .alpha.-methylene-6,11-dioxo- 0.0430505868034761 0.3001034
Total:77  Current:67    [First] [Prev] [Next] [Last]